Do SSRIs lower the risk of long COVID?

Close Up Scientist using microscope in laboratory room while making medical testing and research

Researchers conducted a retrospective study to determine whether SSRIs with immunomodulatory and antiplatelet properties can decrease the risk of post-acute sequelae of COVID-19 (PASC).

The 10 Best and 10 Worst States for Retirees: A Comprehensive Guide

Previous article

Apple’s Emergency SOS via satellite feature is now live. Here’s how it works.

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News